Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Becker

Showing results (141-150 of 335) with videos related to

Pageof 34
Sort By:
Klinische Wochenschrift|May 2, 1986
[Hemoperfusion in flecainide poisoning]R Wurzberger, E Witter, H Avenhaus, et al.
Ugeskrift for Laeger|February 25, 1980
[Treatment of colon dyspepsia with Vi-Siblin]U Becker, L Bjerrum, S Pilgaard, et al.
Resuscitation|April 15, 2008
Anti-arrhythmic and vasopressor medications for the treatment of ventricular fibrillation in severe hypothermia: a systematic review of the literatureCharles R Wira, Joseph U Becker, Gerard Martin, et al.
The Review of Scientific Instruments|March 2, 2015
Ultrastable low-noise current amplifier: a novel device for measuring small electric currents with high accuracyD Drung, C Krause, U Becker, et al.
Journal of Hepatology|February 1, 1997
Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic studyJ H Henriksen, M Grønbaek, S Møller, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver disease. EMALD groupS Møller, U Becker, A Juul, et al.
Gut|June 20, 2001
High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systemsJ H Henriksen, S Møller, S Schifter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)Andres S Wenk, U Becker, S Klawitter, et al.
Deutsches Arzteblatt International|December 19, 2009
Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challengeWolfgang Grotz, Hideo A Baba, Jan U Becker, et al.
Journal of Hepatology|March 1, 1993
Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosisS Møller, M Grønbaek, K Main, et al.
Pageof 34

Showing results (141-150 of 335) with videos related to

Sort By:
Pageof 34
Klinische Wochenschrift|May 2, 1986
[Hemoperfusion in flecainide poisoning]R Wurzberger, E Witter, H Avenhaus, et al.
Ugeskrift for Laeger|February 25, 1980
[Treatment of colon dyspepsia with Vi-Siblin]U Becker, L Bjerrum, S Pilgaard, et al.
Resuscitation|April 15, 2008
Anti-arrhythmic and vasopressor medications for the treatment of ventricular fibrillation in severe hypothermia: a systematic review of the literatureCharles R Wira, Joseph U Becker, Gerard Martin, et al.
The Review of Scientific Instruments|March 2, 2015
Ultrastable low-noise current amplifier: a novel device for measuring small electric currents with high accuracyD Drung, C Krause, U Becker, et al.
Journal of Hepatology|February 1, 1997
Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic studyJ H Henriksen, M Grønbaek, S Møller, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Prognostic value of insulinlike growth factor I and its binding protein in patients with alcohol-induced liver disease. EMALD groupS Møller, U Becker, A Juul, et al.
Gut|June 20, 2001
High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systemsJ H Henriksen, S Møller, S Schifter, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Disappearance of B-Symptoms In Comorbid Patients Receiving First-Line Obinutuzumab (Ga101) -Chlorambucil (G-Clb) Or Rituximab-Chlorambucil (R-Clb) for Chronic Lymphocytic Leukemia (Cll)Andres S Wenk, U Becker, S Klawitter, et al.
Deutsches Arzteblatt International|December 19, 2009
Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challengeWolfgang Grotz, Hideo A Baba, Jan U Becker, et al.
Journal of Hepatology|March 1, 1993
Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosisS Møller, M Grønbaek, K Main, et al.
Pageof 34